… of tumor progression, especially after being programmed and polarized into a
proangiogenic/immunosuppressive (M2-like) phenotype by the tumor … target for blocking tumor …

… of multiple other components within the tumor microenvironment, including immune cells, …
in tumor progression, emphasizing the opportunity these interactions afford to target platelets …

… Herein, we discuss the initiation and resolution of inflammation, the crosstalk between
tumor development and inflammatory processes. We also highlight potential targets for …

… The above data reveals the dual function of P2X7 receptor in regulating tumor progression.
Therefore, P2X7 receptors can be considered potential targets for tumor therapy based on …

… tumor cell proliferation and migration blockade, PC inhibitors can also be used to target tumor
… cellular functions that impact on the invasive/metastatic potential of cancer cells. Thus, PC …

… However, its cancerspecific expression makes mesothelin a potential target for monoclonal
antibody therapy. New human monoclonal antibodies targeting mesothelin have been …

… also released from neurons to favor tumor progression, while cancer cells secrete axon
guidance molecules, directing nerve outgrowth in the tumor microenvironment. Interestingly, EVs …

… The good news is that we have now identified specific genetic abnormalities in nearly every
human cancer and thus have potential targets for therapies that are relatively nontoxic to …

… II in angiogenesis, tumor progression and metastasis. Compelling evidence from the literature
and our own findings suggest that annexin II may be a potential target for the development …

… In the following part, we will describe the role of the main members of neurotransmitters
family in tumor progression, and we will analyze the potential therapeutical implications …